TP53 and hepatocellular carcinoma: As shown in Fig 2, the summary SEN and SPE for IHC-determined p53 overexpression in the diagnostic prediction of p53 mutations in HCC were 0.83 (95% CI: 0.80–0.86) and 0.74 (95% CI: 0.71–0.76), respectively.